Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03919396Not ApplicableCompleted

Effectiveness of Myopia Control by Breath-O Correct Orthokeratology Lenses

Role: collaborator

NCT04618510Not ApplicableUnknown

SEED-LVPEI Myopia Study

Role: collaborator

NCT03616600Not ApplicableCompleted

The Safety and Effectiveness of Breath-O Lenses

Role: collaborator

All 3 trials loaded